Widely recognized as a preeminent thought leader in digital therapeutics, Ed joins EVERSANA from Dthera Sciences, where as its CEO, he earned the FDA’s Breakthrough Device designation for a digital therapeutic to treat the behavioral symptoms of Alzheimer’s disease. His pioneering work in this field has led him to serve in highly visible roles at numerous digital therapeutic and digital medicine events throughout the world, including DTx-Science (Bordeaux, France), LSX World Congress (London, UK), CNS Summit (Boca Raton, FL), DTx West (San Mateo, CA), and Evercore Healthcare Conference (Boston, MA). Ed ...read more